Hong Kong Industrial REITs Stock News

With a median price-to-earnings (or "P/E") ratio of close to 13x in Hong Kong, you could be forgiven for feeling...

While 3SBio Inc. ( HKG:1530 ) shareholders have enjoyed a good week with stock up 10%, they need remain vigilant. In...

The board of directors of Hansoh Pharmaceutical Group announced that China's National Medical Products Administration has accepted the New Drug Application for HS-10365 capsules, a selective RET inhibitor for treating adult patients with RET fusion-positive locally advanced or metastatic non-small cell lung cancer. This regulatory milestone not only reflects progress in Hansoh’s oncology pipeline, but also highlights the company’s potential to address significant unmet needs in lung cancer...

Impro Precision Industries (SEHK:1286) just posted a strong year-on-year jump in third quarter revenue, with standout gains in its diversified industrials and AI-related segments. The company’s positive sales outlook continues to draw attention from investors. See our latest analysis for Impro Precision Industries. Momentum has clearly shifted in Impro Precision Industries’ favor, with the share price climbing 12.87% over the past month and surging 65% in the last quarter. That is part of a...

Key Insights Significant control over TUHU Car by individual investors implies that the general public has more power...

Those holding Magnus Concordia Group Limited ( HKG:1172 ) shares would be relieved that the share price has rebounded...

China Environmental Technology and Bioenergy Holdings Limited ( HKG:1237 ) shareholders won't be pleased to see that...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Crystal International Group's (HKG:2232) stock is up by a considerable 18% over the past three months. Since the market...

In recent announcements by CSPC Pharmaceutical Group, the company received approval to begin clinical trials for its innovative siRNA drug SYH2061 targeting complement component C5, and its co-developed HER2-targeting antibody-drug conjugate JSKN003 was granted Breakthrough Therapy Designation in China for advanced colorectal cancer. These regulatory milestones highlight CSPC’s expanding capabilities in developing first-in-class treatments addressing significant unmet clinical needs within...

Chery Automobile (SEHK:9973) has been trading in a relatively narrow range, with its share price closing at HK$32.38. Over the past month, the stock edged up by 1%, reflecting investors’ cautious optimism. See our latest analysis for Chery Automobile. Momentum has been fairly muted for Chery Automobile, as this year’s modest 1.4% share price return suggests investors are still waiting to see if recent progress translates into stronger growth. After a flurry of updates earlier in the year, the...

Ascletis Pharma (SEHK:1672) has drawn attention this week by selecting ASC36, a once-monthly amylin receptor agonist, as its next clinical candidate for obesity treatment. The company intends to submit an IND for ASC36 to the U.S. FDA in 2026. See our latest analysis for Ascletis Pharma. Ascletis Pharma’s run of pipeline news, including the latest about ASC36, has helped fuel market momentum, even as recent weeks saw some volatility. After an incredible year-to-date share price return of...

Innovent Biologics (SEHK:1801) just reported a 40% jump in product revenue for the third quarter, fueled by strong growth in both its established oncology portfolio as well as newer offerings like mazdutide and SINTBILO. See our latest analysis for Innovent Biologics. Innovent’s shares have been on a rollercoaster in recent weeks, but momentum is clearly building overall. The stock’s 1-year total shareholder return sits at an impressive 148%, even after some profit-taking since last month...

Shanghai Henlius Biotech (SEHK:2696) has entered a strategic partnership with Forlong Biotechnology to jointly develop next-generation cancer immunotherapies. This move brings together Henlius’s antibody expertise and Forlong’s engineered cytokine technologies, further expanding Henlius’s oncology pipeline. See our latest analysis for Shanghai Henlius Biotech. Shanghai Henlius Biotech’s latest partnership news comes at a time when its stock has seen remarkable momentum, with the 1-year total...

Weichai Power Co., Ltd. reported earnings for the nine months ended September 30, 2025, posting sales of CNY 170.57 billion and net income of CNY 8.88 billion, both higher than the same period last year. The results showed an increase in both revenue and basic earnings per share from continuing operations, highlighting ongoing improvement in profitability and operational scale. With solid gains in sales and earnings, we'll examine how Weichai Power's consistent financial growth impacts its...

Li Ning (SEHK:2331) just held its Q3 2025 earnings call, drawing focused attention from investors and analysts. These quarterly updates provide a revealing look at the company’s financial health and management’s outlook for the months ahead. See our latest analysis for Li Ning. Li Ning’s Q3 earnings call appears to have been a catalyst for movement, with the share price rising 1.75% on the day but pulling back 7.05% over the past week. While short-term volatility remains, the company’s total...

Summit Therapeutics recently announced that results from multiple Phase III trials of ivonescimab, a first-in-class bispecific antibody developed by Akeso for cancer treatment, were presented at major medical meetings and published in The Lancet, with strong positive findings for non-small cell lung cancer (NSCLC) patients in China. This clinical progress has already contributed to regulatory approval, imminent U.S. regulatory submission, and inclusion in China's National Reimbursement Drug...

Ever wondered if Lenovo Group is truly a bargain, or if the market is missing something big? You are in the right place to dig into what is really driving value for this tech giant. Lenovo Group’s stock has been anything but flat, with a 16.0% year-to-date climb and an impressive 162.2% gain over the last five years, though it dipped -1.4% this week as the market recalibrated expectations. Global headlines have swirled around Lenovo's expansion in AI-powered devices and fresh investment in...

MTR Corporation Limited recently announced a US$25 billion debt issuance programme with an application for listing on the Hong Kong Stock Exchange, available for 12 months from October 31. This substantial planned capital raise highlights MTR's intent to secure funding for future development, operational support, or potential refinancing amid changing market conditions. We'll assess how this significant debt programme may influence MTR's future financial flexibility and reshape its long-term...

PICC Property and Casualty Company Limited ( HKG:2328 ) has announced that it will pay a dividend of CN¥0.263 per share...

Investors who take an interest in Greentown Management Holdings Company Limited ( HKG:9979 ) should definitely note...

The Geotech Holdings Ltd. ( HKG:1707 ) share price has fared very poorly over the last month, falling by a substantial...

The AUX International Holdings Limited ( HKG:2080 ) share price has softened a substantial 27% over the previous 30...

Those holding Fineland Living Services Group Limited ( HKG:9978 ) shares would be relieved that the share price has...